Table 4 Laboratory and radiologic findings of children and adults with COVID-19 during convalescence
From: Clinical characteristics of 134 convalescent patients with COVID-19 in Guizhou, China
Total N = 134 | Children N = 22 | Adults N = 112 | P value | |
|---|---|---|---|---|
Blood routine | ||||
Leukopenia | 43/134 (32.1%) | 6/22 (27.3%) | 37/112 (33.0%) | 0.597 |
Lymphopenia | 9/134 (6.7%) | 0/22 | 9/112 (8.0%) | 0.362 |
Neutropenia | 33/134 (24.6%) | 9/22 (40.9%) | 24/112 (21.4%) | 0.053 |
Blood biochemistry | ||||
ALT increased | 48/134 (35.8%) | 3/22 (13.6%) | 45/112 (40.2%) | 0.018 |
AST increased | 19/134 (14.2%) | 3/22 (13.6%) | 16/112 (14.3%) | > 0.99 |
Total bilirubin increased | 3/134 (2.2%) | 0/22 | 3/112 (2.7%) | > 0.99 |
Albumin decreased | 7/134 (5.2%) | 1/22 (4.5%) | 6/112 (5.4%) | > 0.99 |
Creatinine increased | 1/134 (0.7%) | 0/22 | 1/112 (0.9%) | > 0.99 |
CKMB increased | 15/134 (11.2%) | 6/22 (27.3%) | 9/112 (8.0%) | 0.025 |
LDH increased | 4/134 (3.0%) | 0/22 | 4/112 (3.6%) | > 0.99 |
Troponin increased | 0/130 | 0/21 | 0/109 | |
Inflammation-related indicators | ||||
ESR increased | 63/97 (64.9%) | 6/19 (31.6%) | 57/78 (73.1%) | 0.001 |
CRP increased | 32/134 (23.9%) | 3/22 (13.6%) | 29/112 (25.9%) | 0.218 |
PCT increased | 3/126 (2.4%) | 1/21 (4.8%) | 2/105 (1.9%) | 0.424 |
Coagulation function | ||||
D-dimer increased | 21/120 (17.5%) | 3/22 (13.6%) | 18/98 (18.4%) | 0.828 |
Chest CT findings | ||||
Normal | 61 (45.5%) | 16 (72.7%) | 45 (40.2%) | 0.005 |
Ground-glass opacity | 40 (29.9%) | 1 (4.5%) | 39 (34.8%) | 0.005 |
Local patchy shadowing | 13 (9.7%) | 2 (9.1%) | 11 (9.8%) | > 0.99 |
Bilateral patchy shadowing | 25 (18.7%) | 0 | 25 (22.3%) | 0.014 |
Interstitial abnormalities | 4 (3.0%) | 2 (9.1%) | 2 (1.8%) | 0.126 |
Fibrosis | 36 (26.9%) | 1 (4.5%) | 35 (31.3%) | 0.010 |